oxovanadium iv has been researched along with Diabetes Mellitus, Type 2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, W; Gong, G; Huang, X; Xu, J | 1 |
| Guo, Y; Jie, X; Liu, Y; Wang, J; Xue, C; Zhang, X | 1 |
| Castro, MM; López-Larrubia, P; Metelo, AM; Pérez-Carro, R | 1 |
| Goto, T; Kawamura, I; Kimura, C; Sakurai, H; Seki, J; Takeshita, S; Tamura, A; Yamamoto, T; Yasuno, T | 1 |
4 other study(ies) available for oxovanadium iv and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Schiff base oxovanadium complexes resist the assembly behavior of human islet amyloid polypeptide.
Topics: Antidiarrheals; Diabetes Mellitus, Type 2; Humans; Islet Amyloid Polypeptide; Protein Aggregates; Schiff Bases; Vanadates | 2018 |
Green Synthesis of Oxovanadium(IV)/chitosan Nanocomposites and Its Ameliorative Effect on Hyperglycemia, Insulin Resistance, and Oxidative Stress.
Topics: Animals; Chitosan; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Stability; Glucose Tolerance Test; Green Chemistry Technology; Hyperglycemia; Insulin Resistance; Liver; Male; Mice, Inbred C57BL; Nanocomposites; Oxidative Stress; Vanadates | 2016 |
VO(dmpp)2 normalizes pre-diabetic parameters as assessed by in vivo magnetic resonance imaging and spectroscopy.
Topics: Animals; Body Weight; Diabetes Mellitus, Type 2; Glucose Intolerance; Lipid Metabolism; Liver; Magnetic Resonance Imaging; Obesity; Organometallic Compounds; Radiography; Rats; Rats, Zucker; Subcutaneous Fat; Triglycerides; Vanadates | 2012 |
Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode.
Topics: 3T3 Cells; Adipose Tissue; Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Kinetics; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Organometallic Compounds; Phosphoproteins; Phosphorylation; Triglycerides; Tumor Necrosis Factor-alpha; Vanadates | 2001 |